Kee Kiat Yeo - Concepedia

Author

Kee Kiat Yeo

Dana-Farber/Boston Children's Cancer and Blood Disorders Center ORCID

Also Known As

Kee K Yeo, Kee K. Yeo, Kee Kiat Yeo, Kee Kiat Yeo*, Kee Yeo

Publications

924

Citations

H-Index

Concepts

All Affiliations

Dana-Farber/Boston Children's Cancer and Blood Disorders Center Boston Children's Hospital Children's Hospital of Los Angeles Brigham and Women's Hospital Harvard University

About

Kee Kiat Yeo is an author at Dana-Farber/Boston Children's Cancer and Blood Disorders Center specializing in medicine, neuro-oncology, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	267
2	Pathology	4	4	77
3	Immunology	2	2	98
4	Neurology	2	2	92
5	Radiation Medicine	1	1	11

Kee Kiat Yeo

Publications

625

Citations

H-Index

Page 1

	Year	Citations
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Blood	2021	144
Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience Chantel Cacciotti, Jungwhan John Choi, Sanda Alexandrescu, Journal of Neuro-Oncology Neuro-oncologyRadiation OncologyCancer ImmunosurveillancePediatric Brain TumorsMedicine	2020	72
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma Neevika Manoharan, Jungwhan John Choi, Christine Chordas, Journal of Neuro-Oncology Pediatric Brain TumorsMedicinePediatric Neuro-oncologyNeurologyHigh-grade Gliomas	2020	71
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma Tom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, Neuro-Oncology	2022	56
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial Theodore S. Johnson, Tobey J. MacDonald, Rafał Pacholczyk, Neuro-Oncology	2023	34
The epidemiology of primary and metastatic brain tumors in infancy through childhood Nayan Lamba, Andrew Groves, Matthew Torre, Journal of Neuro-Oncology Neuro-oncologyMetastatic Brain TumorsTumoral PathologyPediatric Brain TumorsPediatric Neurosurgery	2022	33
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics Kee Kiat Yeo, Sanda Alexandrescu, Jennifer Cotter, Neuro-Oncology	2022	29
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance Rachelle Tibbetts, Kee Kiat Yeo, Sakunthala Muthugounder, Cancer Immunology Immunotherapy Neuro-oncologyTumor InnervationMedicineImmunologyImmunoediting	2021	26
IDH-mutant gliomas with additional class-defining molecular events Jared T. Ahrendsen, Matthew Torre, David M. Meredith, Modern Pathology Neuro-oncologyTumor HeterogeneityPathologyIdh-mutant GliomasHigh-grade Gliomas	2021	22
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors Nathan Robison, Kee Kiat Yeo, Adrian P. Berliner, Journal of Neuro-Oncology Neuro-oncologyPediatric Brain TumorsMedicineSpinal OncologySpinal Tumor	2018	21

Page 1